ability
bacteria
activate
terminal
complement
component
serum
patient
cystic
fibrosis
terminal
complement
component
c
c
contribute
host
defense
infection
study
performed
determine
defective
activation
c
c
bacteria
contributes
pathogenesis
recurrent
pulmonary
infection
cystic
fibrosis
bacteria
incubated
serum
patient
cystic
fibrosis
minute
consumption
available
c
serum
control
patient
two
patient
chronic
severe
bronchiectasis
based
result
present
study
unlikely
defective
activation
c
c
contributes
pathogenesis
increased
susceptibility
pulmonary
infection
patient
